Vaxart, Inc. (VXRT)
0.6287
+0.02
(+3.07%)
USD |
OTCM |
Apr 06, 16:00
Vaxart SG&A Expense (TTM) : 17.61M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 32.68M |
| Nuwellis, Inc. | 13.52M |
| Capricor Therapeutics, Inc. | 23.69M |
| Allogene Therapeutics, Inc. | 56.78M |
| Silvergate Capital Corp. | -- |